betula verrucosa allergen extract
Allergenexperimental
Clinical trial activity
3 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2007 (NCT00535639)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetImmunity, desensitized
Immunity, desensitized
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- betula verrucosa allergen extract
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06085963 | N/A | Feb 1, 2023 | Karolinska Institute |
| NCT04912076 | Phase 1 | Sep 17, 2018 | Biomay AG, European Commission, University of Amsterdam, University of Salzburg, University of Southern Denmark |
| NCT00535639 | Phase 1 | Oct 1, 2007 | ALK-Abello, S.A., PhaseOne Trials |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| ALK-Abello, S.A. | For profit | 1 | 1 | 1 | 2007 |
| Biomay AG | For profit | 1 | 0 | 1 | 2018 |
| European Commission | Government | 1 | 0 | 1 | 2018 |
| Karolinska Institute | Academic/Hospital | 1 | 1 | 1 | 2023 |
| PhaseOne Trials | For profit | 1 | 0 | 1 | 2007 |
| University of Amsterdam | Academic/Hospital | 1 | 0 | 1 | 2018 |
| University of Salzburg | Academic/Hospital | 1 | 0 | 1 | 2018 |
| University of Southern Denmark | Academic/Hospital | 1 | 1 | 1 | 2018 |
8 organizations
Page 1 / 1